Metropolis Healthcare to acquire 51% stake in Shraddha Diagnostic Centre

16 Jan 2020 Evaluate

Metropolis Healthcare has executed Share Purchase and Shareholders' Agreement for the acquisition of 51% shareholding in Shraddha Diagnostic Centre (I). The purpose of the acquisition is to strengthen the presence of the company in the state of Gujarat, India.

Metropolis Healthcare offers a comprehensive range of clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.

Metropolis Health. Share Price

1979.80 -0.40 (-0.02%)
28-May-2024 15:31 View Price Chart
Peers
Company Name CMP
Aster DM Healthcare 380.10
Apollo Hospital Ent. 5911.05
Max Healthcare Inst 792.35
Narayana Hrudayalay 1191.40
Global Health 1228.25
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.